PMAM
ANIP icon

Picton Mahoney Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Picton Mahoney Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54K Hold
20
– – ﹤0.01% 1063
2025
Q4 		$1.58K Hold
20
– – ﹤0.01% 998
2025
Q3 		$2K Hold
20
– – ﹤0.01% 803
2025
Q2 		$1K Hold
20
– – ﹤0.01% 740
2025
Q1 		$1K Hold
20
– – ﹤0.01% 713
2024
Q4 		$1K Hold
20
– – ﹤0.01% 611
2024
Q3 		$1K Buy
+20
New +$1.22K ﹤0.01% 603

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Picton Mahoney Asset Management's ANIP Position: Q1 2026 in Review

Picton Mahoney Asset Management held its ANI Pharmaceuticals (ANIP) position steady in Q1 2026 at 20 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1063.

Picton Mahoney Asset Management first reported a position in ANIP in Q3 2024 and has held it in 7 quarters since. The position peaked at $2K in Q3 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Picton Mahoney Asset Management held 20 shares of ANI Pharmaceuticals worth $1.54K as of Q1 2026.
  • Picton Mahoney Asset Management left its ANI Pharmaceuticals share count unchanged in Q1 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #1063 holding.
  • Picton Mahoney Asset Management first reported a position in ANI Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Picton Mahoney Asset Management's ANI Pharmaceuticals position peaked at $2K in Q3 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.